Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Duke Energy Corp (DUK) vs ResMed Inc. (RMD) Price & Performance

Duke Energy CorpTrade
ResMed Inc.Trade

Price performance (Past 24H)

Key statistics

Duke Energy Corp vs ResMed Inc. — how do they compare? Duke Energy Corp trades at $116.63 (market cap $91.10B), while ResMed Inc. trades at $230.22 (market cap $31.89B). The key difference: Duke Energy Corp is far larger — about 2.9× ResMed Inc.'s market cap, and Duke Energy Corp pays the higher dividend (3.71%). Which is the better fit depends on your goals — on Pluang, investors hold Duke Energy Corp for 74 Days and ResMed Inc. for 51 Days on average.

DUKRMD
Market Cap
$91.10B$31.89B
Volume
4,199,050618,314
Sector
UtilitiesHealth
52-Week High
$133.46$277.88
52-Week Low
$113.23$182.82
Typical Hold Time
74 Days51 Days
Enterprise Value
$183.61B$31.24B
Dividend Yield
3.71%1.16%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Duke Energy Corp

Duke Energy (DUK) trades at $116.55, up 0.91% today, with a bullish technical signal despite mixed moving averages. The company shows consistent earnings beats, with Q2 2026 EPS of $1.43 exceeding the $1.30 estimate. Revenue grew to $32.24B in 2025, and net income margin improved to 15.78%. Recent news highlights dividend declarations and data center growth opportunities, though rising Treasury yields pose a headwind for utility stocks.

DUK offers a stable dividend and benefits from data center demand, but high debt levels and interest rate sensitivity present risks. Analyst consensus is a Buy with a $134.44 price target, implying 15% upside. The stock's valuation is reasonable with a P/E of 17.6, supporting a cautious bullish outlook amid macroeconomic pressures.

ResMed Inc.

ResMed (RMD) trades at $228.37, up 1.06% today, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15B in 2025, with a robust net income margin of 26.94%. Recent news highlights management's presentation at the Morgan Stanley Healthcare Conference and an upcoming Q1 2027 earnings report.

The outlook is positive, supported by earnings growth targets of 12-14% and a consensus price target of $242.70. Key risks include competitive pressures and ongoing legal investigations. Institutional buying activity and analyst upgrades reflect confidence, but investors should monitor execution against growth targets and any developments from the legal probe.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DUK

No sentiment data available yet.

RMD
80% Buy20% Sell
Avg holding period · 51 Days

Top news

Latest headlines on both assets

About Duke Energy Corp

Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure

Read more on DUK →

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD →